VNDA icon

Vanda Pharmaceuticals
VNDA

Overview Fund Activity

136 hedge funds and large institutions have $556M invested in Vanda Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 46 increasing their positions, 53 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
136
Holders Change
-5
Holders Change %
-3.55%
% of All Funds
3.39%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
21
Increased
46
Reduced
53
Closed
19
Calls
$721K
Puts
$625K
Net Calls
+$96K
Net Calls Change
-$1.23M

Top Buyers

1
BlackRock
1
BlackRock
New York
$53.9M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$34.8M
3
AC
3
Armistice Capital
New York
$22.5M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$22.4M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$34.9M

Top Sellers

1
DM
1
Deerfield Management
New York
$32.2M
2
Acadian Asset Management
2
Acadian Asset Management
Massachusetts
$7.7M
3
CM
3
Castleark Management
Illinois
$0
4
OAM
4
Oxford Asset Management
United Kingdom
$2.79M
5
AL
5
AJO LP
Pennsylvania
$3.91M
Name Holding Trade Value Shares
Change 		Shares
Change %
Group One Trading
151
Group One Trading
Illinois
– -$100K -6,255 Closed
PCM
152
Prelude Capital Management
New York
– -$45K -2,800 Closed
CG
153
Cutler Group
California
– -$41K -2,586 Closed
TRCT
154
Tower Research Capital (TRC)
New York
– -$16K -945 Closed
PHK
155
Point72 Hong Kong
Hong Kong
– -$3K -216 Closed
3 4 5 6
7